Supplemental Table 3 from The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 3. Interaction of LY2409881 with other drugs/compounds in two DLBCL cell line.
Authors: Changchun Deng, Mark Lipstein, Richard Rodriguez, Xavier O. Jirau Serrano, Christine McIntosh, Wei-Yann Tsai, Andrew S. Wasmuth, Susan Jaken, Owen A. O'Connor
Language: English
Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361868783